← Back to headlines
Ocular Therapeutix Drug Shows Promise in Eye Disorder, Falls Short of Investor Hopes
A drug developed by Ocular Therapeutix for an eye disorder has shown promise in clinical trials, but the results did not meet investor expectations.
19 Feb, 23:01 — 19 Feb, 23:01
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Puberty blocker trial paused over ‘new concerns’ about fertility - The Times
40m ago
Medication Linked to Impulsive Behavior and Addictions, Hundreds Report
1h ago
Smartphone Use Linked to Surge in Neck Disk Problems Among Seniors in Korea
1h ago
Puberty blocker trial paused over ‘new concerns’ about fertility - The Times
2h ago